A Next Generation Cell Therapy Company
Minutia A Next Generation
Cell Therapy Company

At Minutia we are working towards a
transplant of insulin producing cells combined with nanosensors for diabetes.

We believe our ability to create more robust and controlled insulin producing cell transplants that can be monitored in vivo over time will revolutionize the current clinical landscape for diabetes and cell replacement therapy.

Latest News

Minutia's Science is Supported by these Non-dilutive Funders

Minutia